Strides Pharma Science (BOM:532531) Change In Receivables : ₹0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Strides Pharma Science Change In Receivables?

Strides Pharma Science's change in receivables for the quarter that ended in Dec. 2024 was ₹0 Mil. It means Strides Pharma Science's Accounts Receivable stayed the same from Sep. 2024 to Dec. 2024 .

Strides Pharma Science's change in receivables for the fiscal year that ended in Mar. 2024 was ₹391 Mil. It means Strides Pharma Science's Accounts Receivable declined by ₹391 Mil from Mar. 2023 to Mar. 2024 .

Strides Pharma Science's Accounts Receivable for the quarter that ended in Dec. 2024 was ₹0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Strides Pharma Science's Days Sales Outstanding for the three months ended in Dec. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Strides Pharma Science's liquidation value for the three months ended in Dec. 2024 was ₹0 Mil.

Strides Pharma Science Change In Receivables Historical Data

The historical data trend for Strides Pharma Science's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strides Pharma Science Change In Receivables Chart

Strides Pharma Science Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

-1,591.07

-1,247.75

-587.95

-3,473.79

390.90

Strides Pharma Science Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Strides Pharma Science Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Strides Pharma Science (BOM:532531) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Strides Pharma Science's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	11536.67	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Strides Pharma Science's accounts receivable are only considered to be worth 75% of book value:

Strides Pharma Science's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	0	+	0.75 * 0	+	0.5 * 0
=	0

Strides Pharma Science Change In Receivables Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Strides Pharma Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (BOM:532531) » Definitions » Change In Receivables

Traded in Other Exchanges

STAR:India

Address

Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076

Website

https://www.strides.com

Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market plan focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. The company's reportable segment are; Pharmaceutical & Bio-pharmaceutical.

Strides Pharma Science Headlines

No Headlines